Introduction
============

Like human beings, conventional rodents harbor trillions of bacteria and viruses ([@B58]). Germ-free (GF) animals, instead, are completely free of these microbes. In the field of gnotobiology \[from the Greek "*gnōtos"* (known) and *"biotic"* (life)\] ([@B22]), such animals are used to study the effects of inoculation with specific, known microbes. To raise GF mice, researchers must separate pups from their mother's wombs surgically, by aseptic cesarean or hysterectomy, thus avoiding contact with microorganisms present in the mother's vagina and skin. Alternatively, GF pups can also be generated via the process of embryo transfer, which occurs in an isolator environment and thus enables the implantation of cleansed embryos into GF recipients under well-controlled conditions. A recipient female gives birth normally and cares for the offspring as if they were her own pups, thus enhancing the pups' survival rate. GF pups are kept in a sterile environment their whole lives. In order to guarantee GF status, recurrent contamination tests are performed on their feces. Once GF animals have been produced, it is possible to expand the colony by crossing GF individuals. The new members of the colony have a natural birth and continue their life under the same sterile conditions as their progenitors.

The accuracy of GF technology lies in the ability to control the composition of the environment in which an organism develops and functions ([@B15]). To this end, gnotobiotic facilities eliminate microbes present in food, water, and bedding through specific sterilization protocols. Typically, these materials are heated to temperatures above 100°C in order to kill bacteria and viruses. Possible contamination is prevented through a fail-safe double-door system, in which autoclaved supply cylinders are docked to a double-door port built into the isolator wall. These security measures enable inoculation by a single microorganism of interest, as well as the consequent reproduction of mono-associated animals, known as monoxenics. Animals inoculated with two microorganisms are known as dixenics, those with three are trixenics, and so on (**Figure [1A](#F1){ref-type="fig"}**) In the 1960s, Schaedler (Rockefeller University) investigated the effects of different mixtures of bacteria in GF mice. He was the first to study how a specific bacterium colonizes the gut of initially GF mice ([@B44],[@B45]), and his descriptions of what subsequently became known as the "Schaedler flora" have served as important tools in standardizing the microbiota of laboratory populations of rodents around the world ([@B44],[@B45]). This microbiota has recently been updated to include extremely oxygen-sensitive (EOS) bacteria, which were not included in the first survey due to the technical difficulties inherent in their isolation ([@B60]). Nowadays, this altered Schaedler microbiota (ASF) is used in several laboratories around the world for the study of bacteria-host dynamics ([@B60]). In addition, the ability to control the microbiota also enables the transfer of a simplified or complete human microbiota to the GF animals in order to create human-like conditions ([@B21]) (**Figure [1B](#F1){ref-type="fig"}**). However, if the transferred microbiota is not completely defined, the resulting animals are not considered gnotobiotic animals.

![**Different models derived from germ-free (GF) mice. (A)** Gnotobiotic models: GF mice can be colonized by one bacterium (microorganism A) in order to obtain A-mono-associated mice. Similarly, GF mice can be colonized by microorganisms A and B to obtain A + B di-associated mice. When mice are colonized by a basic microbiota such as the altered Schaedler Flora (ASF), we obtain mice with a simplified microbiota. **(B)** Non-gnotobiotic models: when mice are colonized by human microbiota from healthy or unhealthy individuals (normally with dysbiosis), we obtain mice with human-associated microbiota (HMA).](fmicb-07-00409-g001){#F1}

Typically, gnotobiotic animals are used to study the effects of different members of the microbiota on the host. As is the case with most biological research ([@B58]), the field of gnotobiotics began with studies in which the system of interest---in this case, the microbiota of various animals such as mice, rats, guinea pigs, and chicks---was removed in order to examine its role in different processes ([@B41]).

Studies with these animals have demonstrated that the crosstalk between microbes and their host is essential for the well-being of the host, and have indicated that the physiology of healthy host individuals is dependent on the composition of the gut microbiota. Indeed, changes in the gut microbiota affect processes as varied as epithelial cell renewal, differentiation, and architecture ([@B7]); intestinal motility ([@B15]); and host glycosylation patterns and gene expression ([@B24]). The study of gnotobiotic rodents has also allowed researchers to identify and characterize key microbes responsible for the development of the intestinal immune system ([@B56]; [@B55]). Thanks to gnotobiology, it is now widely recognized that the microbiome serves its hosts in capacities that go far beyond its role in food digestion. GF animals have dramatic alterations in practically every phenotype that has been studied, including the immune system, brain development, metabolism, behavior, and the function of the heart, lungs, and lymph nodes ([@B58]). In addition, the combination of gnotobiotic techniques with other new approaches has revealed causative associations between alterations in the commensal microbiota and diseases such as inflammatory bowel disease (IBD), obesity, and multiple sclerosis, among others ([@B1]; [@B27]; [@B53]; [@B4]).

Why Use Gnotobiotic Rodents in Studies of Microbe--Microbe Interactions?
========================================================================

In the mammalian gut, microbes exist in a complex network of cooperation and competition. Simplified experimental culture conditions, in many cases, do not adequately represent the *in vivo* activities and connections among different members of the network, which prevents accurate evaluations of their individual contributions to overall microbiota functionality ([@B46]). Instead, gnotobiology offers a model in which microbe--microbe interactions can be assessed directly in a more complex environment. Furthermore, the use of initially GF animals enables complete knowledge of the microbial composition of a host, with consequent advantages for the interpretation of results compared to studies of conventional mice. For all these reasons, gnotobiotic studies offer a wide range of advantages compared to both other animal models and *in vitro* conditions. Gnotobiotics represents the optimal compromise between the realistic complexity of conventional rodents and the controlled nature of *in vitro* tests, without the incomplete knowledge and control of the environment inherent in the former and the oversimplifications of the latter.

Gnotobiotics as a Model of Synergistic Microbial Interactions (Cooperative Network Analysis)
--------------------------------------------------------------------------------------------

The diverse intestinal microbiota is characterized by extensive synergistic ecological interactions ([@B46]). Gnotobiotic animals have been employed for deeper analyses of these important microbial interactions, in particular (i) bacterial succession, (ii) cross-feeding, and (iii) phage regulation of bacterial populations.

Most studies of bacterial succession have focused on the initial gut colonization process (primo-colonization; [@B16]). In these studies, different bacteria are introduced (sequentially or not) into GF animals in order to mimic the progressive colonization of the sterile intestine that begins immediately after birth. For instance, [@B52] compared the transfer of two different microbiota to GF rats: one from suckling rats, rich in early colonizing bacteria, and the other obtained from adult rats, representative of a mature microbiota. In rats with the early colonizing microbiota, strictly anaerobic bacteria succeeded aero-tolerant bacteria. Because of this coordinated process of bacterial succession, at the end of the experiment the microbiotas of both groups had converged on the same species profile, that of the mature inoculum. Similar results have been described for the process of microbiota acquisition in conventional mice ([@B20]). However, the mechanisms behind this succession remain poorly described, as this study focused only on host responses and not the evolution in microbe--microbe interactions ([@B52]).

Aero-tolerant bacteria are thought to "prepare" the colonic environment for the growth of the strictly anaerobic bacteria that will later predominate. Researchers have taken advantage of this phenomenon to introduce certain strictly anaerobic bacteria into mice with a controlled microbiota. For example, the bacterium *Faecalibacterium prausnitzii* has well-known anti-inflammatory properties that contribute to its role as a sensor and promoter of intestinal health ([@B34], [@B33]). However, because it is EOS, it is quite difficult to obtain monoxenic *F. prausnitzii*-associated rodents. By preparing the environment with *Escherichia coli*, though, [@B32] were able to generate gnotobiotic mice that harbored both *F. prausnitzii* and *E. coli*. Similarly, dixenic *F. prausnitzii*-associated rats were also obtained by first inoculating the rats with *Bacteroides thetaiotaomicron* ([@B59]) (**Figure [2](#F2){ref-type="fig"}**). *B. thetaiotaomicron* is an anaerobic bacterium; rather, it decreases the oxido-reductive potential of the gastrointestinal tract (GIT), thus enabling colonization by *F. prausnitzii*. In addition, *B. thetaiotaomicron* and *F. prausnitzii* complement each other metabolically: the former is acetate-producing whereas the latter is acetate-consuming and butyrate-producing ([@B12]; [@B28]). In di-associated rats, *B. thetaiotaomicron* produces acetate and *F. prausnitzii* transforms this into butyrate ([@B59]). These short-chain fatty acids (SCFAs) are also able to stimulate the host response. For instance, SCFA trigger pleiotropic signals in the host, including signals regulating mucin synthesis and secretion ([@B19]; [@B5]). Both of these dixenic models illustrate the importance of bacterial interactions during the colonization of GF rodents by microorganisms. Since strictly anaerobic bacteria are major components of the intestinal microbiota, these mutualistic relationships are likely of vital importance in microbiota acquisition and maintenance.

![***Bacteroides thetaiotaomicron* (gray oval) and *Faecalibacterium prausnitzii* (black oval) di-associated mice production process. (A)** When *B. thetaiotaomicron* and *F. prausnitzii* were inoculated individually (gray arrows), only *B. thetaiotaomicron* colonized. **(B)** *F. prausnitzii* was successfully implanted after week 4 following three weekly inoculations (black arrows). The oxido-reductive potential (measured by Eh value) in the cecum progressively decreased in the presence of *B. thetaiotaomicron* (from 178 mV in GF rats to 141.1 mV at day 2) and decreased further in the presence of *F. praustnizii* (-274 mV at day 30). Comparison of *B. thetaiotaomicron* mono-associated rats with dixenic rats revealed that in the presence of *F. praustnizii* there was a decrease in pH and acetate and an increase in butyrate. Adapted from [@B59].](fmicb-07-00409-g002){#F2}

As mentioned above, the study of bacterial cross-feeding phenomena is one area in which the tools of gnotobiology will continue to be indispensable. Special models of human microbiota have been developed for this purpose, as only 15% of the bacterial species found in mice are also present in humans ([@B51]). Human microbiota-associated (HMA) mice have also been employed as models in the study of the ecology and metabolism of the human intestinal microbiota ([@B23]). For instance, studies of GF mice colonized by human microbiota have clarified the cross-feeding activities of *Akkermansia muciniphila* ([@B57]), a highly specialized bacterium capable of utilizing mucus as a sole carbon and nitrogen source ([@B11]; [@B14]). The mucus-degrading ability of *A. muciniphila* and its localization within the mucus layer have revealed its specific niche and function within the gut ([@B50]; [@B38]). By degrading mucus, *A. muciniphila* has the ability to produce SCFAs (acetate and propionate) ([@B11]), which can stimulate microbiota interactions and a host response. Specifically, oligosaccharides and acetate stimulate growth and metabolic activity in commensal bacteria growing close to the mucus layer, which may in turn discourage pathogenic bacteria from crossing the mucus layer to reach the intestinal cells ([@B11], [@B10], [@B9]). Furthermore, an increase in acetate and propionate due to the degradation of mucus by *A. muciniphila* could stimulate other bacterial groups with well-known butyrate-producing capacities as it has been proved *in vitro* with other acetate producers ([@B42]).

Other scientific research on the human microbiome has stimulated interest in probiotics, health-promoting agents that are able to modulate the intestinal microbiota. In a recent experiment, HFA mice were used to study the ability of *Bifidobacterium longum* strain BB536 to modulate the gut environment ([@B49]). HFA mice that were supplemented with strain BB536 showed increased fecal levels of butyrate and pimelate, a precursor of biotin. In addition, the BB536-supplemented mice also had metabolic alterations related to biotin synthesis, specifically involving *Bacteroides caccae* and the increased prevalence of *Eubacterium rectale*, a butyrate producer ([@B49]). All these possible interactions of *B. longum* BB536 with the microbial community might explain, at least in part, various reports of its beneficial physiological effects on the host, including anti-allergy effects, competition against harmful bacteria, and improvement in defecation frequency and stool characteristics ([@B37], [@B36]; [@B61]; [@B35]).

Gnotobiotics also offers clear advantages for the study of phage-bacteria dynamics in the human gut. Bacterial viruses (phages) are the most abundant biological group on earth ([@B43]). In some ecosystems, they are capable of maintaining high levels of diversity of bacterial strains through lysis of their hosts, in a process described by the constant-diversity dynamics model of bacterial diversity; this model is based on the fact that many of the genes that differ between strains affect regions that are potential phage recognition targets ([@B43]). Recently, Reyes and coworkers introduced sequenced human gut bacteria into GF mice and followed this with a controlled phage attack using virus-like particles (VLPs) purified from the fecal microbiota ([@B43]). The authors observed transient changes in bacterial community structure and bacterial acquisition of resistance to phage attack through both ecological and epigenetic mechanisms. These results illustrate the utility of gnotobiotic mice in characterizing ecological relationships among all components in the gut, viruses as well as bacteria.

Gnotobiotic Animals as Models of Antagonistic Microbial Interactions (Competitive Network Analysis)
---------------------------------------------------------------------------------------------------

Microbe--microbe interactions are not always cooperative. Antagonistic cross-talk is a fundamental link in microbial ecology and vital for the maintenance of host health. Gnotobiotic animals have been employed to obtain deeper insight into the ability of the microbiota to protect against infections, a process termed colonization resistance ([@B48]).

Alterations in microbiota homeostasis generally result in dysbiosis, an imbalance among bacterial species that often occurs in the digestive tract. This condition, also known as dysbacteriosis, is associated with illnesses such as IBD, chronic obesity, cancer, and bacterial vaginosis ([@B30], [@B29],[@B31]). Efforts to link these diseases to specific changes in the microbiota have been hindered, though, by a lack of knowledge of healthy bacterial communities. Indeed, it is not well understood if dysbiosis itself is a consequence or a cause of an imbalance in bacteria--bacteria relationships in the gastrointestinal tract.

When colonization resistance is disrupted through antibiotic-mediated perturbations in the microbiota or other similar phenomena, infections by nosocomial pathogens tend to increase ([@B54]; [@B48]). This observation could be explained by the 1983 proposal of [@B17],[@B18]) that populations of most intestinal bacteria are held in check by competition for limited substrates. GF animals provide an ideal testing ground in which to explore this hypothesis, as the level of competition within a particular host can be manipulated through the introduction of varying numbers of bacterial strains. Studies using this approach have found that, because they lack competing bacterial species, GF animals are more susceptible than conventional ones to infections by *E. coli, Clostridium difficile, Vibrio cholerae*, or *Citrobacter rodentium* ([@B8]; [@B6]; [@B47]; [@B25]; [@B39]). This hypothesis was further supported by experiments in which the transplantation of healthy fecal microbiota increased host resistance ([@B2]; [@B13]; [@B26]). Thus, Freter's theory provides a straightforward explanation of why gnotobiotic mice are more sensitive to nosocomial infections: the lack of substrate competition reduces barriers to colonization. However, this conclusion is probably over-simplistic. Nowadays, studies from various fields, including gnotobiology, have concluded that colonization resistance is the result of not only a highly complex interplay among members of the commensal microbiota, but also of interactions among the microbiome \[the entire community of microbes and their genetic material; ([@B29]), the intestinal mucosa, and the immune system ([@B48])\]. For example, GF mice have been used to examine how individual bacteria species or bacterial communities influence colonization resistance to *C. difficile*. In particular, GF mice that had been inoculated only with a murine isolate from the family *Lachnospiraceae* demonstrated partially restored colonization resistance to *C. difficile* ([@B39]), confirming that the indigenous microbial community of the GIT and the inter-relationships among its members determine susceptibility to colonization and growth of *C. difficile* ([@B40], [@B39]). These results highlight the potential of gnotobiotic mice as a controlled environment in which to study antagonist microbial interactions.

Colonization resistance is not the only example of antagonistic interactions in the microbiota. For example, gnotobiotic models have also been used to analyze growth competition between the well-known yoghurt bacteria *Streptococcus thermophilus* and *Lactobacillus delbrueckii* ssp. *bulgaricus*. The growth and lactate production of these two bacteria were monitored in different media and in the GIT of GF rats. When GF rats were not supplemented with lactose, they were colonized only by *S. thermophilus*, not by *L. bulgaricus*. However, when the rats' drinking water was supplemented with lactose, both bacteria were able to colonize. Interestingly, when lactose-supplemented GF rats were inoculated with a mix of both bacteria, *S. thermophilus* colonized the GIT faster and more extensively than *L. bulgaricus* did. This work showed that *S. thermophilus* has a competitive and growth advantage over *L. bulgaricus in vitro* as well as *in vivo* in the GIT of GF rats ([@B3]).

Future Trends in Gnotobiology
=============================

At this point, gnotobiology is a mature science with applications that go far beyond conventional ones. The classical experiments and protocols used routinely in the study of microbes' interactions with their hosts can easily be modified in order to investigate interactions between and among multiple members of the microbiota. As an example, a study aiming to understand the effect of a microbe of interest on a particular disease would benefit greatly from the use of mice with a controlled, described microbiota. Such mice would then also be the perfect experimental system in which to analyze the relationship of the same microbe with the rest of the microbiota. Furthermore, this analysis could be performed in both healthy and diseased hosts. Similarly, our understanding of a pathogen's activity in a host could be enhanced through the use of various monoxenic mice: such mice could be infected with a pathogen and monitored in order to directly assess the effect of individual resident microorganisms on the disease caused by the pathogen. This model presents unique opportunities to analyze the possible antagonistic interactions between resident and invading microorganisms.

In brief, the options with gnotobiology are almost unlimited. Furthermore, the combination of gnotobiotics with new-*omics* approaches (e.g., transcriptomics, metabolomics, and genomics) and molecular genetics (genetically modified mice and bacteria) could provide important insights into the roles of microbe--microbe interactions. This knowledge could improve our understanding of how commensal bacteria change into opportunistic pathogens, how pathogens are able to proliferate, and how probiotic bacteria could help to resolve dysbiosis.

Concluding Remarks
==================

Here, we have summarized the most important outcomes of gnotobiological research in the field of microbe--microbe interactions as well as other concerns with relevance to the field. The most significant questions in microbiota analysis, including microbial interaction, rely on gnotobiotic animals for further advancements in the field. GF animals will be indispensable in future investigations of how certain microorganisms are able to colonize and survive in the host, while others, e.g., pathogens, are not. Studies of interaction and communication within the microbiota will also depend heavily on gnotobiotic approaches.
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